Free Trial

Motus GI (MOTS) Competitors

Motus GI logo

MOTS vs. NMRD, UTRS, VIVE, DRTSW, ANZUW, ATAKW, BBLGW, HSCSW, BEATW, and LUCYW

Should you be buying Motus GI stock or one of its competitors? The main competitors of Motus GI include Nemaura Medical (NMRD), Minerva Surgical (UTRS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), and Innovative Eyewear (LUCYW). These companies are all part of the "medical equipment" industry.

Motus GI vs. Its Competitors

Nemaura Medical (NASDAQ:NMRD) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, analyst recommendations, profitability and risk.

Motus GI has higher revenue and earnings than Nemaura Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nemaura Medical$3.02K0.00-$14.14M-$0.39N/A
Motus GI$319K0.00-$12.87M-$15.64N/A

Nemaura Medical has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, Motus GI has a beta of 1.01, meaning that its stock price is 1% more volatile than the S&P 500.

Company Net Margins Return on Equity Return on Assets
Nemaura MedicalN/A N/A N/A
Motus GI N/A N/A N/A

In the previous week, Nemaura Medical's average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.

Company Overall Sentiment
Nemaura Medical Neutral
Motus GI Neutral

4.4% of Nemaura Medical shares are owned by institutional investors. Comparatively, 20.1% of Motus GI shares are owned by institutional investors. 40.4% of Nemaura Medical shares are owned by insiders. Comparatively, 0.3% of Motus GI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Motus GI beats Nemaura Medical on 5 of the 7 factors compared between the two stocks.

Get Motus GI News Delivered to You Automatically

Sign up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MOTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MOTS vs. The Competition

MetricMotus GISurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$81.77M$5.75B$9.77B
Dividend YieldN/AN/A6.66%4.50%
P/E Ratio0.0011.3262.2622.40
Price / SalesN/A105.03537.34111.77
Price / CashN/A18.4125.7028.92
Price / BookN/A7.4711.196.58
Net Income-$12.87M-$26.48M$3.28B$265.84M

Motus GI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MOTS
Motus GI
0.1218 of 5 stars
N/AN/AN/A$1K$319K0.0030Gap Up
NMRD
Nemaura Medical
0.8235 of 5 stars
N/AN/AN/A$4K$3.02K0.0040
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69M0.00160
VIVE
Viveve Medical
N/A$0.00
flat
N/A-75.0%$1K$6.83M0.0070
DRTSW
Alpha Tau Medical
N/A$0.29
+6.6%
N/AN/A$0.00N/A0.0080Gap Up
ANZUW
Anzu Special Acquisition Corp I
N/A$0.04
-15.3%
N/AN/A$0.00N/A0.002
ATAKW
Aurora Technology Acquisition
N/A$0.01
-3.3%
N/A-56.6%$0.00N/A0.00N/AGap Down
BBLGW
Bone Biologics
N/A$10.79
-28.1%
N/AN/A$0.00N/A0.002
HSCSW
Heart Test Laboratories
N/A$0.06
-2.1%
N/AN/A$0.00$4.35K0.0010Positive News
BEATW
HeartBeam
N/A$0.37
+24.7%
N/AN/A$0.00N/A0.005Positive News
LUCYW
Innovative Eyewear
N/A$0.09
+6.4%
N/A+60.0%$0.00$1.98M0.009Gap Down

Related Companies and Tools


This page (NASDAQ:MOTS) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners